Ligand Pharmaceuticals Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Ligand Pharmaceuticals Inc
TickerLGND
CIK #0000886163
CUSIP53220K504
SectorLife Sciences - Pharmaceutical Preparations
Address11085 North Torrey Pines Road Suite 300, La Jolla, CA 92037
Source [EDGAR]
CIK Filing 2011 - 2025
[0000886163] 10-K
[0000886163] 10-Q
[0000886163] 3
[0000886163] 4
[0000886163] 5
[0000886163] 8-K
[0000886163] D
[0000886163] SC 13D
[0000886163] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Ligand Pharmaceuticals Inc Pelthos Therapeutics Inc [2025-07-03] 0.0
Macquarie Group Ltd Ligand Pharmaceuticals Inc [2024-02-14] 81945.66
Goldman Sachs Group Inc Ligand Pharmaceuticals Inc [2024-02-12] 6.8
State Street Corp Ligand Pharmaceuticals Inc [2021-02-16] 7.25
Macquarie Group Ltd Ligand Pharmaceuticals Inc [2021-02-12] 5.68
Wasatch Advisors Inc Ligand Pharmaceuticals Inc [2021-02-09] 7.3
Cardinal Capital Management LLC /CT Ligand Pharmaceuticals Inc [2020-02-14] 5.2
Bank of America Corp /DE/ Ligand Pharmaceuticals Inc [2020-02-14] 5.8
State Street Corp Ligand Pharmaceuticals Inc [2020-02-14] 7.14
Janus Henderson Group PLC Ligand Pharmaceuticals Inc [2020-01-10] 10.5
Ligand Pharmaceuticals Inc Seelos Therapeutics Inc [2019-04-15] 9.99
Renaissance Technologies LLC Ligand Pharmaceuticals Inc [2019-02-12] 6.97
FMR LLC Ligand Pharmaceuticals Inc [2016-02-12] 0.0
William Blair Investment Management LLC Ligand Pharmaceuticals Inc [2016-02-09] 5.72
KCG Americas LLC Ligand Pharmaceuticals Inc [2016-02-03] 9.63
Ligand Pharmaceuticals Inc Viking Therapeutics Inc [2015-05-08] 49.8
Cardinal Capital Management LLC /CT Ligand Pharmaceuticals Inc [2015-02-12] 5.0
Vanguard Group Inc Ligand Pharmaceuticals Inc [2015-02-10] 5.07
RS Investment Management Co LLC Ligand Pharmaceuticals Inc [2014-02-14] 6.44
FMR LLC Ligand Pharmaceuticals Inc [2014-02-14] 0.0
Blair William & Co/IL Ligand Pharmaceuticals Inc [2014-02-06] 5.96
Vanguard Group Inc Ligand Pharmaceuticals Inc [2013-02-13] 5.32
Ligand Pharmaceuticals Inc Desert Gateway Inc [2013-01-11] 7.44
Park West Asset Management LLC Ligand Pharmaceuticals Inc [2012-12-26] 5.1
BlackRock Inc Ligand Pharmaceuticals Inc [2012-02-09] 6.01
Form 3/4/5 Filer 2011 - 2025
Reardon Andrew
Ligand Pharmaceuticals Inc
Kozarich John W
Pelthos Therapeutics Inc.
Davis Todd C
Espinoza Octavio
Aryeh Jason
Lamattina John L
Zimmermann Martine
Sabba Stephen L
Haas Jason
Gray Nancy Ryan
Korenberg Matthew E
Higgins John L
OmniAb Operations, Inc.
Cochran Jennifer R.
Patel Sunil
Berkman Charles S
Foehr Matthew W
Boyce Sarah
Pfenex Inc.
Viking Therapeutics, Inc.
Goldman Sachs Group Inc
Goldman Sachs & Co LLC
Herman Melanie J
Knott David M
DeSilva Nishan M
Lampert Mark N
Biotechnology Value Fund L P
Biotechnology Value Fund II LP
BVF Investments LLC
BVF Partners L P/IL
BVF Inc/IL
Investment 10 LLC
Sharp John P
Kazmi Syed
Form 13F Holdings
Firm Period DFND Voting Shares
BlackRock, Inc. [2025-06-30] SOLE 2,854,789 2,913,596
Vanguard Group Inc [2025-06-30] SOLE 0 2,049,123
Janus Henderson Group PLC [2025-06-30] DFND 0 1,060,734
Macquarie Group Ltd [2025-06-30] SOLE 903,759 926,554
State Street Corp [2025-06-30] DFND 690,225 749,754
Dimensional Fund Advisors LP [2025-06-30] SOLE 644,585 664,688
Congress Asset Management Co [2025-06-30] SOLE 615,717 647,941
Stephens Investment Management Group LLC [2025-06-30] DFND 0 604,813
Chicago Capital LLC [2025-06-30] SOLE 571,825 571,825
Geode Capital Management LLC [2025-06-30] DFND 488,778 488,778
Loomis Sayles & Co L P [2025-06-30] DFND 403,666 410,897
Massachusetts Financial Services Co /MA/ [2025-06-30] SOLE 339,742 339,742
Rice Hall James & Associates LLC [2025-06-30] SOLE 273,334 337,348
Deutsche Bank AG [2025-06-30] DFND 294,027 307,797
Ashford Capital Management Inc [2025-06-30] SOLE 302,527 302,527
Ranger Investment Management LP [2025-06-30] SOLE 261,250 300,025
Villere St Denis J & Co LLC [2025-06-30] SOLE 286,180 287,120
Impax Asset Management Group plc [2025-06-30] DFND 260,208 260,208
Northern Trust Corp [2025-06-30] DFND 255,768 258,667
Invesco Ltd. [2025-06-30] DFND 0 229,858
Private Capital Management LLC [2025-06-30] DFND 72,255 229,253
Aberdeen Group plc [2025-06-30] DFND 229,230 229,230
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AME [2025-06-30] SOLE 196,950 215,556
Morgan Stanley [2025-06-30] DFND 167,999 202,409
Franklin Resources Inc [2025-06-30] DFND 185,476 186,099
Charles Schwab Investment Management Inc [2025-06-30] SOLE 176,053 176,064
Jacobs Levy Equity Management Inc [2025-06-30] SOLE 131,876 162,810
Driehaus Capital Management LLC [2025-06-30] SOLE 124,589 161,162
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AME [2025-06-30] OTR 1,121 148,350
Bank of New York Mellon Corp [2025-06-30] DFND 116,624 128,106
Prev | Page 1 | Next
Terms | Privacy | Guide
tony@aum13f.com